MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwon, B. K.
Right arrow Articles by Tetzlaff, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, B. K.
Right arrow Articles by Tetzlaff, W.
Molecular Interventions 2:244-258 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics


Review

Molecular Targets for Therapeutic Intervention after Spinal Cord Injury

Brian K. Kwon1,2, Jaimie F. Borisoff1 and Wolfram Tetzlaff1,3

1 International Collaboration on Repair Discoveries (ICORD)
2 Department of Orthopaedics,
3 Department of Surgery, University of British Columbia Vancouver, British Columbia, Canada V6T 1z4


In an effort to develop therapies for promoting neurological recovery after spinal cord injury, much work has been done to identify the cellular and molecular factors that control axonal regeneration within the injured central nervous system. This review summarizes the current understanding of a number of the elements within the spinal cord environment that inhibit axonal growth and outlines the factors that influence the neuron’s ability to regenerate its axon after injury. Recent insights in these areas have identified important molecular pathways that are potential targets for therapeutic intervention, raising hope for victims of spinal cord injury.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Gorio, L. Madaschi, B. Di Stefano, S. Carelli, A. M. Di Giulio, S. De Biasi, T. Coleman, A. Cerami, and M. Brines
From The Cover: Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury
PNAS, November 8, 2005; 102(45): 16379 - 16384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.